1. Home
  2. NGL vs ESPR Comparison

NGL vs ESPR Comparison

Compare NGL & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGL
  • ESPR
  • Stock Information
  • Founded
  • NGL 1940
  • ESPR 2008
  • Country
  • NGL United States
  • ESPR United States
  • Employees
  • NGL N/A
  • ESPR N/A
  • Industry
  • NGL Natural Gas Distribution
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGL Utilities
  • ESPR Health Care
  • Exchange
  • NGL Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • NGL 564.5M
  • ESPR 456.6M
  • IPO Year
  • NGL 2011
  • ESPR 2013
  • Fundamental
  • Price
  • NGL $4.45
  • ESPR $2.52
  • Analyst Decision
  • NGL
  • ESPR Buy
  • Analyst Count
  • NGL 0
  • ESPR 3
  • Target Price
  • NGL N/A
  • ESPR $8.17
  • AVG Volume (30 Days)
  • NGL 289.1K
  • ESPR 5.2M
  • Earning Date
  • NGL 11-12-2024
  • ESPR 11-07-2024
  • Dividend Yield
  • NGL N/A
  • ESPR N/A
  • EPS Growth
  • NGL N/A
  • ESPR N/A
  • EPS
  • NGL N/A
  • ESPR N/A
  • Revenue
  • NGL $6,239,231,000.00
  • ESPR $295,451,000.00
  • Revenue This Year
  • NGL N/A
  • ESPR $198.22
  • Revenue Next Year
  • NGL $3.50
  • ESPR $25.83
  • P/E Ratio
  • NGL N/A
  • ESPR N/A
  • Revenue Growth
  • NGL N/A
  • ESPR 187.12
  • 52 Week Low
  • NGL $3.84
  • ESPR $1.16
  • 52 Week High
  • NGL $6.20
  • ESPR $3.40
  • Technical
  • Relative Strength Index (RSI)
  • NGL 56.50
  • ESPR 64.07
  • Support Level
  • NGL $3.84
  • ESPR $2.02
  • Resistance Level
  • NGL $4.55
  • ESPR $2.60
  • Average True Range (ATR)
  • NGL 0.21
  • ESPR 0.19
  • MACD
  • NGL 0.04
  • ESPR 0.02
  • Stochastic Oscillator
  • NGL 85.87
  • ESPR 89.04

About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, and for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: